Internal Medicine, Gastroenterology · Binghamton, NY
NPI
1104827138
Since 2005
Specialty
Internal Medicine, Gastroenterology
Code 207RG0100X
Group practices
4
Medicare group memberships
Hospitals
3
Hospital affiliations
40 Mitchell Ave
Binghamton, NY, 13903
Phone (607) 772-0639
Groups this clinician bills Medicare through
Medicare paid, 2024
$115K
1,586 services
Medicare patients, 2024
666
Average age 72
Drug cost, 2024
$1.5M
1,833 prescriptions
Company payments, 2025
$123
From 3 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Ali Marhaba was code G0500 (moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito), 407 times for 388 patients. In total Ali Marhaba billed 1,586 services in 56 codes, and Medicare paid $115K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2011-07-11.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|---|---|---|---|---|
| G0500 Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | Facility | 407 | 388 | $3.64 | $1,481 |
| 43239 Upper GI Endoscopy | Facility | 184 | 181 | $65.91 | $12K |
| 45385 Colonoscopy - Lesion Removal | Facility | 170 | 170 | $198.53 | $34K |
| 99214 Office E&M - Established | Facility | 145 | 115 | $68.69 | $9,961 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 122 | 105 | $12.72 | $1,552 |
| 99232 Hospital E&M - Subsequent | Facility | 75 | 66 | $58.96 | $4,422 |
| G0105 Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 65 | 65 | $171.54 | $11K |
| 45380 Lower GI Endoscopy - Other | Facility | 52 | 52 | $122.33 | $6,361 |
| 99213 Office E&M - Established | Facility | 44 | 41 | $44.54 | $1,960 |
| G0121 Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 42 | 41 | $169.62 | $7,124 |
| 43235 Upper GI Endoscopy | Facility | 28 | 28 | $62.11 | $1,739 |
| 43248 Upper GI Endoscopy | Facility | 28 | 28 | $103.54 | $2,899 |
| 43450 Digestive/Gastrointestinal | Facility | 26 | 26 | $31.00 | $806 |
| 99231 Hospital E&M - Subsequent | Facility | 18 | 17 | $35.75 | $644 |
| 43274 Upper GI Endoscopy | Facility | 15 | 11 | $292.77 | $4,392 |
By year: 2022 $123K for 1,517 services; 2023 $118K for 1,433 services; 2024 $115K for 1,586 services.
Medicare prescription drug claims, 2024
In 2024, the drug Ali Marhaba prescribed most often to Medicare patients was Omeprazole, with 228 prescriptions and refills. In total Ali Marhaba wrote 1,833 Medicare prescriptions that cost $1.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Omeprazole Generic | 228 | 535 | 88 | $3,086 |
| Pantoprazole Sodium Generic | 211 | 412 | 73 | $1,918 |
| Famotidine Generic | 120 | 243 | 42 | $1,596 |
| Linzess Linaclotide | 66 | 92 | 21 | $51K |
| Sod Sulf-Potass Sulf-Mag Sulf Sodium, Potassium,mag Sulfates | 62 | 62 | 61 | $3,842 |
| Dicyclomine Hcl Generic | 61 | 91 | 13 | $1,291 |
| Lansoprazole Generic | 52 | 110 | 17 | $777 |
| Mesalamine Generic | 52 | 76 | 15 | $40K |
| Creon Lipase/Protease/Amylase | 50 | 66 | 11 | $68K |
| Mirtazapine Generic | 50 | 66 | 17 | $1,329 |
| Budesonide Ec Budesonide | 47 | 67 | 15 | $31K |
| Buspirone Hcl Generic | 43 | 72 | 18 | $752 |
| Amitriptyline Hcl Generic | 43 | 71 | Under 11 | $311 |
| Prednisone Generic | 34 | 49 | 13 | $179 |
| Stelara Ustekinumab | 33 | 54 | Under 11 | $840K |
Brand drugs: - claims; generic drugs: 1,528 claims; opioid claims: 44.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Ali Marhaba $123 ($123 in general payments such as food, travel and fees) from 3 companies. The largest payer was Abbvie Inc. with $79.66.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.